Why the study?
Heart failure patients demonstrate reduced functional capacity, hemodynamic function, and quality of life associated with high morbidity and mortality, but the relationship between these factors needed assessment.
Does peak O2 consumption or hemodynamic response to exercise correlate with quality of life in chronic heart failure patients?
Does peak O2 consumption or hemodynamic response to exercise correlate with quality of life in chronic heart failure patients?
Peak O2 consumption, but not hemodynamic response to exercise, is a significant determinant of quality of life in chronic heart failure patients.
Peak VO2 was associated with QOL in chronic HF; leaves open whether exercise hemodynamics contribute independently.
Background Heart failure patients demonstrate reduced functional capacity, hemodynamic function, and quality of life (QOL) which are associated with high mortality and morbidity rate. The aim of the present study was to assess the relationship between functional capacity, hemodynamic response to exercise and QOL in chronic heart failure. Methods A single-centre prospective study recruited 42 chronic heart failure patients (11 females, mean age 60 ± 10 years) with reduced left ventricular ejection fraction (LVEF = 23 ± 7%). All participants completed a maximal graded cardiopulmonary exercise test with non-invasive hemodynamic (bioreactance) monitoring. QOL was assessed using Minnesota Living with Heart Failure Questionnaire. Results The average value of QOL score was 40 ± 23. There was a significant negative relationship between the QOL and peak O 2 consumption (r = − 0.50, p ≤ 0.01). No significant relationship between the QOL and selected exercise hemodynamic measures was found, including peak exercise cardiac power output (r = 0.15, p = 0.34), cardiac output (r = 0.22, p = 0.15), and mean arterial blood pressure (r = − 0.08, p = 0.60). Conclusion Peak O 2 consumption, but not hemodynamic response to exercise, is a significant determinant of QOL in chronic heart failure patients.
No takes yet. Share an insight, caveat, or question.
Fatrin et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: